This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Influenza A H7N4 Neuraminidase (NA), N-His
Product Overview
BioVenic's Recombinant Influenza A H7N4 Neuraminidase (NA), N-His is a recombinant protein expressed from E.coli Expression System. Its predicted molecular weight is 45.2 kDa. The purity is>90% (SDS-PAGE).
Specifications
Target Information
Neuraminidase is a tetrameric surface glycoprotein of the H7N4 Influenza A virus, a subtype that has demonstrated the ability to cross the species barrier from birds to humans. As a glycosyl hydrolase, NA cleaves terminal sialic acid residues on the host cell surface. This enzymatic action is crucial for releasing newly formed virions from the cell membrane and preventing their sequestration by mucus. H7N4 NA is a key focus for surveillance and the development of neuraminidase inhibitors to mitigate potential pandemic threats.
Shipping and Storage
This product is shipped with gel ice bags. Avoid repeated freezing and thawing. Store for 12 months at -20°C or -80°C.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquote the reconstituted solution to minimise freeze-thaw cycles.
